Breaking News

Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here

Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Close

Novartis AG ADR (NVSN)

	Symbol	Exchange	Currency
	NVS	NYSE	USD	Real-time
	NOVNz	BATS Europe	CHF	Delayed
	NVSEF	OTC Markets	USD	Delayed
	0QLR	London	CHF	Real-time
	NVSN	Mexico	MXN	Delayed
	NOVN	Switzerland	CHF	Delayed
	NOVZn	Frankfurt	EUR	Delayed

Add to/Remove from Watchlist Add to Watchlist

1,639.26 0.00 0.00%

22/06 - Closed. Currency in MXN ( Disclaimer )

Type: Equity

Market: Mexico

ISIN: US66987V1098

S/N: 66987V109

Volume: 0
Bid/Ask: 0.00 / 0.00
Day's Range: 1,639.26 - 1,639.26

News
Analysis & Opinion

NVSN Analysis

This page features the latest analysis and reports for the Novartis AG ADR stock.

Tezcan Gecgil/Investing.com

2 ETFs For Betting On A Rebound In European Stocks By Tezcan Gecgil/Investing.com - Mar 31, 2022

Concerns over high inflation levels and the war in Ukraine have meant increased volatility for stocks on Wall Street and other exchanges around the world. For instance, the DAX index of blue-chip...

Tezcan Gecgil/Investing.com

2 ETFs On Track To Benefit From The Fed's New Interest Rate Hike Cycle By Tezcan Gecgil/Investing.com - Mar 21, 2022 4

Interest rates in the US are going up. The country's red-hot inflation level has prompted the Federal Reserve to step in to achieve its dual mandate of "price stability and maximum sustainable...

Christine Short

Shareholder Meetings, Conferences Ramp Up Ahead Of Q3 Earnings Season By Christine Short - Sep 10, 2021 2

Executive Summary Shareholder meetings and conferences ramp up after a busy summer and ahead of the next earnings season The Delta variant forced many companies to quickly switch to webcasts and...

Protalix: Leveraging Tech In Developing Therapies For Orphan Diseases By Ari Zoldan - Jul 04, 2021

Protalix Biotherapeutics (NYSE:PLX) is a drug discovery company that develops therapies for orphan diseases. Protalix has been leveraging its proprietary ProCellEx® platform, which is the key to...

3 Simple Steps To “Recurring” Dividends That Grow Every Year (Forever) By Brett Owens - Feb 16, 2021

Today we’re going to discuss the secret to double-digit annual returns every year, forever, with secure dividend stocks. It’s simple but not easy. Here’s the hint. We must seek out...

Tezcan Gecgil/Investing.com

2 ETFs For Value Investors, Just In Time As Markets Rotate Out Of Tech Shares By Tezcan Gecgil/Investing.com - Dec 15, 2020 2

Value investors aim to capture returns by investing in cheap assets, like stocks, and rotating out of expensive ones. As we get ready to wrap up 2020, many market participants wonder if value...

Tollbooth Stocks Offering Dividend Growth By Brett Owens - Oct 06, 2020

Election chaos—especially after Friday’s bombshell—could be a knockout blow for this market bounce. I’m worried. And going by our Contrarian Outlook mailbag, plenty of readers are, too. A typical...

The Stocks Most Impacted By The 2020 U.S. Presidential Election By Matthew Weller - Aug 12, 2020 6

As we approach the 2020 election, you must be wondering: how will the elected candidate impact the stock market and certain key stocks in particular? Experience tells us that it is a challenge to...

Zacks Investment Research

Jazz's (JAZZ) Xyrem Follow-On Candidate NDA Gets FDA Acceptance By Zacks Investment Research - Mar 25, 2020

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) announced that the FDA has accepted the new drug application (“NDA”) seeking approval for JZP-258 as a treatment for cataplexy and excessive...

Zacks Investment Research

Novartis To Donate Generic Hydroxychloroquine For Coronavirus By Zacks Investment Research - Mar 22, 2020

Novartis AG (NYSE:NVS) announced that it will provide up to 130 million doses of generic hydroxychloroquine to support the treatment of the global COVID-19 pandemic.The donation comes at a time when...

1 2 3 4 5 6 7 8 9 10

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read Investing.com's comments guidelines and agree to the terms described.

NVS Comments

Write your thoughts about Novartis N

Are you sure you want to delete this chart?

Post also to:

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Zoran Labus Mar 25, 2021 11:02AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

https://seekingalpha.com/pr/18243773-sellas-life-sciences-reports-full-year-2020-financial-results-and-provides-business-update

0 1

Pankaj Negi Jan 20, 2021 1:09PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

buy

1 0

Pete Pete Sep 30, 2020 12:02PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

A

0 0

stats con chris Jun 17, 2020 12:12PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

just to know. I'm lost.this is the company that bought the medicines company?

0 0

Stoffel Sep 17, 2019 4:42PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

before investing in @novartis, read #teampia (twitter).

0 0

Kast Feb 07, 2019 2:02AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

sell 89 expecting 80 timeframe 5 days

1 1

Robin Hood Sep 28, 2018 7:12PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Long ENDOCYTE... I work in the field

0 0

Episcopolian1 Jul 19, 2017 11:04AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

$NVS: Novartis AG Looking at All Options Including IPO for Alcon Unit.. This is HUGE catalyst for $NVS share holders!!!!!

1 0

Episcopolian1 Jul 10, 2017 11:51AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Buy this stock tomorrow as will be halted all day on Wednesday!

0 0

Episcopolian1 Jul 07, 2017 10:39AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

I am willing to bet that FDA advisory committee WILL recommend their CTL019 drug!Post

0 0

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="201243953">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="201243953" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="201243953">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="201243953">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d1-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
		</div>
    </div>
			</div>
			<div id="show-more-comments">
				<a class="showMoreComments block">
					<span class="arial_12 showArrowafter">Show more comments (<span class="js-amount"></span>)</span>
				</a>
			</div>
			<div id="show-more-replies">
				<a class="showMoreReplies block">
					<span class="arial_12 showArrowafter">Show more replies (<span class="js-amount"></span>)</span>
				</a>
			</div>

Are you sure you want to delete this chart?

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

	US 30	30,916.5	-180.8	-0.58%
	US 500	3,801.1	-24.2	-0.63%
	Dow Jones	31,097.26	+321.83	+1.05%
	S&P 500	3,825.33	+39.95	+1.06%
	Nasdaq	11,127.84	+99.11	+0.90%
	S&P 500 VIX	26.70	-2.01	-7.00%
	Dollar Index	104.855	-0.054	-0.05%

	Crude Oil WTI	108.26	-0.17	-0.16%
	Brent Oil	111.47	-0.16	-0.14%
	Natural Gas	5.693	+0.073	+1.30%
	Gold	1,812.40	+10.90	+0.61%
	Silver	19.767	+0.100	+0.51%
	Copper	3.5960	-0.0130	-0.36%
	US Soybeans	1,510.50	-48.50	-3.11%

	SPDR S&P 500	381.24	+3.99	+1.06%
	iShares Russell 2000	171.41	+2.05	+1.21%
	Invesco QQQ Trust	282.13	+1.85	+0.66%
	Direxion Daily Junior Gold Miners Bull 2X Shares	35.44	+1.98	+5.92%
	iShares Silver	18.31	-0.33	-1.77%
	ProShares Ultra VIX Short-Term Futures	13.99	-0.54	-3.72%
	ProShares UltraPro QQQ	24.39	+0.39	+1.62%

	Apple	138.93	+2.21	+1.62%
	Alphabet A	2,174.75	-4.51	-0.21%
	Tesla	681.79	+8.37	+1.24%
	Amazon.com	109.56	+3.35	+3.15%
	Netflix	179.95	+5.08	+2.90%
	Meta Platforms	160.03	-1.22	-0.76%
	Bank of America	31.56	+0.43	+1.38%

Recent Quotes

	Name	Price	Chg.	Chg. %
	NVSN	1,639.26	0.00	0.00%

	Name	Last	Chg. %	Vol.
	AMD	73.67	-3.66%	87.36M
	AMZN	109.56	+3.15%	72.25M
	AAPL	138.93	+1.62%	70.44M
	NVDA	145.23	-4.20%	57.42M
	META	160.03	-0.76%	31.11M
	TSLA	681.79	+1.24%	24.66M
	MSFT	259.58	+1.07%	22.43M

	Name	Last	Chg. %	Vol.
	ETSY	79.81	+9.02%	5.65M
	DOCU	61.22	+6.69%	7.47M
	PHM	42.22	+6.54%	3.36M
	CRWD	179.25	+6.34%	3.71M
	WBD	14.25	+6.18%	23.12M
	OKTA	95.98	+6.17%	2.42M
	DDOG	101.05	+6.10%	3.82M

	Name	Last	Chg. %	Vol.
	LRCX	394.83	-7.35%	2.93M
	KLAC	296.26	-7.15%	2.32M
	ASML	449.83	-5.47%	1.57M
	AMAT	86.27	-5.18%	12.99M
	MPWR	364.95	-4.97%	769.37K
	NVDA	145.23	-4.20%	57.42M
	TER	85.80	-4.19%	1.86M